About Bitco Pharmaceutical
Established in 2022, we are an active corporate pharmaceutical company focused on designing, manufacturing, and supplying premium B2B drug formulations under stringent quality codes.
Our Corporate Story
Bitco Pharmaceutical was founded with a singular, vital mission: to bridge the gap between premium, high-bioavailability clinical formulations and affordable pricing structures. Under the steering guidance of our founder, **K.M. Priyadarshni**, the company has grown from a regional distributor into a nationwide therapeutic solution provider.
Headquartered in North Delhi, Vardhman Central Mall, we operate through specialized therapeutic segments focusing on Orthopedics, Gynecology, Antacids, and general Vitamin wellness. We prioritize chelated molecules and advanced delivery mechanisms (like enteric pellets and oral nano liquid solutions) to provide specialists with predictable clinical efficacy.
"To be a global beacon of quality healthcare, designing science-backed pharmaceutical ranges that doctors prescribe with trust and patients consume with confidence."
"At BITCO, our growth is powered by our core dedication to 'Care & Quality'. We challenge industry conventions by deploying superior raw ingredients, chelated trace elements, and transparent B2B distribution rights. Together with our medical advisors, we are paving a brighter future for Indian healthcare."
Our Core Values
Quality First
We ensure every drug batch complies strictly with WHO-GMP and Schedule M regulatory testing protocols.
Patient Centricity
Our active compositions are designed with advanced chelated and nano-emulsified vectors to yield maximum patient outcomes.
Affordable Care
We believe that premium pharmaceutical solutions must be economically viable, ensuring accessibility for all.
Scientific Integrity
R&D directs our formulation choices, avoiding unnecessary fillers and backing claims with clinical research.
Quality Control Standards
Our quality mandate is governed by absolute adherence to international safety metrics. Raw Active Pharmaceutical Ingredients (APIs) are vetted for microbial load and heavy metals before formulation. We partner with state-of-the-art facilities equipped with modern HVAC units to prevent airborne contamination.
- HPLC (High-Performance Liquid Chromatography) batch audits.
- Dissolution testing to guarantee optimal drug absorption kinetics.
- Real-time stability chambers checking shelf-life across temperature shifts.
Research & Development (R&D)
We focus our R&D on formulation design, particularly addressing absorption inhibitors in the human gut. By opting for amino acid chelates (e.g. Zinc and Ferrous Bisglycinates) and micro-encapsulated probiotics (like Probiotic Lysatum Inactivatum), we bypass standard drug degradation steps, ensuring rapid and predictable patient outcomes.
- Physiological 40:1 ratio optimization for inositol PCOS therapies.
- Advanced nano-emulsified drug vectors for lipid-soluble vitamins.
- Clean excipient policy minimizing artificial binders.
Milestones & History
Inception & Licensing
Bitco Pharmaceutical Private Limited incorporated in Delhi, securing regulatory drug approvals and establishing core quality testing partnerships.
Women's Health Divisions
Launched our specialized gynaecology and PCOS divisions, introducing targeted formulations nationally.
Orthopedic Therapeutics
Established joint rebuilding and pain management segments, introducing advanced formulations and liquid vitamin D3 shots to major orthopedic clinics.
FY 25-26 Cycle Target
Aligned operations toward expanding clinical networks and scaling distribution reach across north-Indian physician segments.